Skip to main content
Log in

Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Blood and urine acylcarnitine profiles are commonly used to diagnose long-chain fatty acid oxidation disorders (FAOD: i.e., long-chain hydroxy-acyl-CoA dehydrogenase [LCHAD] and carnitine palmitoyltransferase 2 [CPT2] deficiency), but the global metabolic impact of long-chain FAOD has not been reported. We utilized untargeted metabolomics to characterize plasma metabolites in 12 overnight-fasted individuals with FAOD (10 LCHAD, two CPT2) and 11 healthy age-, sex-, and body mass index (BMI)-matched controls, with the caveat that individuals with FAOD consume a low-fat diet supplemented with medium-chain triglycerides (MCT) while matched controls consume a typical American diet. In plasma 832 metabolites were identified, and partial least squared-discriminant analysis (PLS-DA) identified 114 non-acylcarnitine variables that discriminated FAOD subjects and controls. FAOD individuals had significantly higher triglycerides and lower specific phosphatidylethanolamines, ceramides, and sphingomyelins. Differences in phosphatidylcholines were also found but the directionality differed by metabolite species. Further, there were few differences in non-lipid metabolites, indicating the metabolic impact of FAOD specifically on lipid pathways. This analysis provides evidence that LCHAD/CPT2 deficiency significantly alters complex lipid pathway flux. This metabolic signature may provide new clinical tools capable of confirming or diagnosing FAOD, even in subjects with a mild phenotype, and may provide clues regarding the biochemical and metabolic impact of FAOD that is relevant to the etiology of FAOD symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • American College of Medical Genetics Newborn Screening Expert Group (2006) Newborn screening: toward a uniform screening panel and system. Genet Med 8(1):1s–252s

  • Bach AC, Babayan VK (1982) Medium-chain triglycerides: an update. Am J Clin Nutr 36(5):950–962

    Article  CAS  PubMed  Google Scholar 

  • Bakermans AJ et al (2013) Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse. Cardiovasc Res 100(3):441–449

    Article  CAS  PubMed  Google Scholar 

  • Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B Method 57(1):289–300

    Google Scholar 

  • Cajka T, Fiehn O (2014) Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. TrAC Trend Anal Chem 61:192–206

    Article  CAS  Google Scholar 

  • Cole LK, Vance JE, Vance DE (2012) Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim Biophys Acta (BBA) Molecul Cell Biol Lipid 1821(5):754–761

    Article  CAS  Google Scholar 

  • Development Core Team (2005) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria

  • Domingues MRM, Reis A, Domingues P (2008) Mass spectrometry analysis of oxidized phospholipids. Chem Phys Lipids 156(1–2):1–12

    Article  CAS  PubMed  Google Scholar 

  • Fiehn O, Kind T (2007) Metabolite profiling in blood plasma. Methods Mol Biol 358:3–17

    Article  CAS  PubMed  Google Scholar 

  • Fiehn O, Wohlgemuth G, Scholz M (2005) Setup and annotation of metabolomic experiments by integrating biological and mass spectrometric metadata. In: Ludäscher B, Raschid L (eds) Data integration in the life sciences. Springer, Berlin, pp 224–239

    Chapter  Google Scholar 

  • Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688:1–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gillingham MB et al (2013) Altered body composition and energy expenditure but normal glucose tolerance among humans with a long-chain fatty acid oxidation disorder. Am J Physiol Endocrinol Metab 305(10):E1299–E1308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Houten SM et al (2013) Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects. Hum Mol Genet 22(25):5249–5261

    Article  CAS  PubMed  Google Scholar 

  • Jacobs RL et al (2008) Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein. J Biol Chem 283(4):2147–2155

    Article  CAS  PubMed  Google Scholar 

  • Jenkins B, West JA, Koulman A (2015) A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (c15:0) and heptadecanoic acid (c17:0) in health and disease. Molecules 20(2):2425–2444

    Article  PubMed  Google Scholar 

  • Kim H, Golub GH, Park H (2005) Missing value estimation for DNA microarray gene expression data: local least squares imputation. Bioinformatics 21(2):187–198

    Article  CAS  PubMed  Google Scholar 

  • Kind T et al (2013) LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat Methods 10(8):755–758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kontush A, Chapman MJ (2010) Lipidomics as a tool for the study of lipoprotein metabolism. Curr Atheroscler Rep 12(3):194–201

    Article  CAS  PubMed  Google Scholar 

  • Lahti L et al (2013) Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data. Peer J 1:e32

  • Matyash V et al (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49(5):1137–1146

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McCoin CS, Knotts TA, Adams SH (2015) Acylcarnitines: old actors auditioning for new roles in metabolic physiology. Nat Rev Endocrinol 11(10):617–625

  • Mehmood T et al (2012) A review of variable selection methods in partial least squares regression. Chemomet Intell Lab Syst 118:62–69

    Article  CAS  Google Scholar 

  • Mevik B-H, Wehrens R (2007) The pls package: principal component and partial least squares regression in R. J Stat Soft 18(2):1–24

    Article  Google Scholar 

  • Najdekr L et al (2015) Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency. Talanta 139:62–66

    Article  CAS  PubMed  Google Scholar 

  • Orngreen MC et al (2005) Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol 57(1):60–66

    Article  CAS  PubMed  Google Scholar 

  • Piccolo BD et al (2015) Whey protein supplementation does not alter plasma branched-chained amino acid profiles but results in unique metabolomics patterns in obese women enrolled in an 8-week weight loss trial. J Nutr doi: 10.3945/​jn.114.203943

  • Rinaldo P, Matern D, Bennett MJ (2002) Fatty acid oxidation disorders. Annu Rev Physiol 64:477–502

    Article  CAS  PubMed  Google Scholar 

  • Rinaldo P, Cowan TM, Matern D (2008) Acylcarnitine profile analysis. Genet Med 10(2):151–156

    Article  PubMed  Google Scholar 

  • Roe CR et al (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110(2):259–269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scholz M, Fiehn O (2007) SetupX—a public study design database for metabolomic projects. Pac Symp Biocomput 2007:169–80

  • Smith EH, Matern D (2010) Acylcarnitine analysis by tandem mass spectrometry. Curr Protoc Hum Genet Chapter 17:p. Unit 17.8.1–20

  • Troyanskaya O et al (2001) Missing value estimation methods for DNA microarrays. Bioinformatics 17(6):520–525

    Article  CAS  PubMed  Google Scholar 

  • Tucci S et al (2014) Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD−/−) mice. Bioch Biophys Acta (BBA) Molecul Bas Dis 1842(5):677–685

    Article  CAS  Google Scholar 

  • Wanders RJ et al (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 22(4):442–487

    Article  CAS  PubMed  Google Scholar 

  • Watson MS et al (2006) Main Report. Genet Med 8:12S–252S

  • Wilcken B et al (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. New England J Med 348(23):2304–2312

    Article  CAS  Google Scholar 

  • Wold S, Sjöström M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. Chemomet Intell Lab Syst 58(2):109–130

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Oliver Fiehn of the West Coast Metabolomics Center at UC Davis for his support of the metabolomics and lipidomics analysis. The West Coast Metabolomics Center is supported by NIH Grant U24 DK097154. Additionally, the authors would like to thank Dr. John Newman of the USDA Western Human Nutrition Research Center for his support in interpretation of the lipidomics analysis as well as Dr. Paul Coen of the Translational Research Institute for Metabolism and Diabetes for his insightful comments and review of this manuscript. The genesis of this project emerged from results from grants awarded by the NIH-NIDDK (R01DK078328 and R01DK078328-02S1, to S.H.A. and K01DK071869, to M.G.) and USDA-ARS intramural Project 5306-51530-019-00, and the studies supported by a UC Davis Clinical and Translational Science Center (CTSC) Pilot Award (to S.H.A., J.V., M.G.) funded by the NIH National Center for Advancing Translational Sciences, through grant number UL1TR000002. This project was also supported by a NIH T32 pre-doctoral training award (to C.S.M.), funded by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR000002 and linked award TL1 TR000133. J.V. was supported in part by R01-DK78755. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sean H. Adams.

Ethics declarations

Conflict of interest

None.

Informed consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Written informed consent was obtained from all patients or legal guardians prior to inclusion in the study.

Additional information

Communicated by: Ronald JA Wanders

Colin S. McCoin and Brian D. Piccolo contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Table 1

Complete data set containing quantifier ion peak heights (QIPH) for untargeted plasma metabolomics and lipidomics from healthy control subjects (n = 11) and individuals with FAOD diagnosed with LCHAD (n = 10) or CPT2 (n = 2) (XLSX 428 kb)

Supplemental Table 2

Bootstrapped variable importance in projection (VIP) statistics from partial least squared-discriminant analyses (PLS-DA) of Model 1 and Model 2 from plasma of healthy control (n = 11) and FAOD (n = 12) individuals with FAOD (XLSX 39.3 kb)

Supplemental Table 3

Diagnostic and supplementation information for FAOD subjects (XLSX 14 kb)

Supplemental Table 4

Plasma acylcarnitine analysis performed on 10 h fasted FAOD and healthy control subjects (XLSX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McCoin, C.S., Piccolo, B.D., Knotts, T.A. et al. Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation. J Inherit Metab Dis 39, 399–408 (2016). https://doi.org/10.1007/s10545-016-9915-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-016-9915-3

Navigation